These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12857598

  • 1. Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages.
    Johnston TP, Li Y, Jamal AS, Stechschulte DJ, Dileepan KN.
    Mediators Inflamm; 2003 Jun; 12(3):147-55. PubMed ID: 12857598
    [Abstract] [Full Text] [Related]

  • 2. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP, Zhou X.
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [Abstract] [Full Text] [Related]

  • 3. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME, Palinski W, Ylä-Herttuala S, Carew TE.
    Toxicol Pathol; 1990 Apr; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [Abstract] [Full Text] [Related]

  • 4. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR, Moulton KS, Kazlauskas A.
    Circ Res; 2007 Aug 17; 101(4):357-67. PubMed ID: 17615372
    [Abstract] [Full Text] [Related]

  • 5. The effect of poloxamer 407 on the functional properties of HDL in mice.
    Yasuda T, Johnston TP, Shinohara M, Inoue M, Ishida T.
    J Pharm Pharmacol; 2012 May 17; 64(5):677-87. PubMed ID: 22471363
    [Abstract] [Full Text] [Related]

  • 6. Proatherogenic effects of the cholesterol ozonolysis products, atheronal-A and atheronal-B.
    Takeuchi C, Galvé R, Nieva J, Witter DP, Wentworth AD, Troseth RP, Lerner RA, Wentworth P.
    Biochemistry; 2006 Jun 13; 45(23):7162-70. PubMed ID: 16752907
    [Abstract] [Full Text] [Related]

  • 7. Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice.
    Lau PP, Li L, Merched AJ, Zhang AL, Ko KW, Chan L.
    Arterioscler Thromb Vasc Biol; 2006 Jan 13; 26(1):143-9. PubMed ID: 16254210
    [Abstract] [Full Text] [Related]

  • 8. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages.
    Boullier A, Li Y, Quehenberger O, Palinski W, Tabas I, Witztum JL, Miller YI.
    Arterioscler Thromb Vasc Biol; 2006 May 13; 26(5):1169-76. PubMed ID: 16484596
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL.
    Norata GD, Tonti L, Roma P, Catapano AL.
    Nutr Metab Cardiovasc Dis; 2002 Oct 13; 12(5):297-305. PubMed ID: 12616810
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec 13; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein activated macrophages in co-culture with mesangial and endothelial cells: nitric oxide and tissue injury.
    Mohan PF.
    Biomed Sci Instrum; 1997 Dec 13; 33():544-9. PubMed ID: 9731419
    [Abstract] [Full Text] [Related]

  • 12. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U.
    Circulation; 2008 May 06; 117(18):2377-87. PubMed ID: 18443241
    [Abstract] [Full Text] [Related]

  • 13. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.
    Persson J, Nilsson J, Lindholm MW.
    Lipids Health Dis; 2006 Jun 26; 5():17. PubMed ID: 16800873
    [Abstract] [Full Text] [Related]

  • 14. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 15. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ, Chan L.
    Circulation; 2004 Dec 21; 110(25):3830-41. PubMed ID: 15596565
    [Abstract] [Full Text] [Related]

  • 16. Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 mice.
    Johnston TP.
    J Pharm Pharmacol; 2010 Dec 21; 62(12):1807-12. PubMed ID: 21054409
    [Abstract] [Full Text] [Related]

  • 17. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA.
    Circulation; 2007 Jan 30; 115(4):501-8. PubMed ID: 17242282
    [Abstract] [Full Text] [Related]

  • 18. [Experimental models of atherosclerosis. Contribution, limits and trends].
    Hadjiisky P, Bourdillon MC, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1991 Nov 30; 84(11):1593-603. PubMed ID: 1763926
    [Abstract] [Full Text] [Related]

  • 19. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.
    Yeh M, Cole AL, Choi J, Liu Y, Tulchinsky D, Qiao JH, Fishbein MC, Dooley AN, Hovnanian T, Mouilleseaux K, Vora DK, Yang WP, Gargalovic P, Kirchgessner T, Shyy JY, Berliner JA.
    Circ Res; 2004 Oct 15; 95(8):780-8. PubMed ID: 15388640
    [Abstract] [Full Text] [Related]

  • 20. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
    Seehaus S, Shahzad K, Kashif M, Vinnikov IA, Schiller M, Wang H, Madhusudhan T, Eckstein V, Bierhaus A, Bea F, Blessing E, Weiler H, Frommhold D, Nawroth PP, Isermann B.
    Circulation; 2009 Sep 01; 120(9):774-84. PubMed ID: 19687358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.